Compare BioNano Genomics Inc (BNGO) vs Motorola Solutions Inc (MSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Motorola Solutions Inc — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while Motorola Solutions Inc trades at $469.39 (market cap $77.26B). The key difference: Motorola Solutions Inc is far larger — about 5655.9× BioNano Genomics Inc's market cap, and Motorola Solutions Inc pays a 1.04% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | MSI | |
|---|---|---|
Market Cap | $13.66M | $77.26B |
Sector | Health | Technology |
52-Week High | $4.92 | $490.30 |
52-Week Low | $1.06 | $363.83 |
Enterprise Value | $16.26M | $86.17B |
Dividend Yield | — | 1.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.19, up 2.59% today, with bullish technical signals from moving averages. The company shows improving financials with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable. Recent earnings have consistently beaten expectations, and analyst sentiment is positive with 57% buy ratings. Key developments include debt retirement and scientific publications highlighting optical genome mapping adoption.
The outlook is cautiously optimistic given improving fundamentals and positive analyst coverage, but significant risks remain due to persistent losses and negative cash flow. Investment opportunity lies in the company's technology adoption growth, while primary risks include profitability challenges and competitive pressures in the genomics space.
Motorola Solutions (MSI) trades at $466.53, up 0.98% today, with a bullish technical outlook and strong fundamentals. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $4.41 exceeding expectations, and the company raised its full-year guidance. Revenue growth is robust, supported by a record backlog of $15.6 billion, while profitability remains high with a net income margin of 17.44%.
The outlook is positive given strong demand in public safety and software services, though valuation multiples are elevated. Key risks include execution challenges and macroeconomic sensitivity. Analyst consensus is bullish with a $533.80 price target, implying significant upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →
